2020 (ACoP11): Co-Organizer, moderator/host, panelist, (winning) team coach
Is Pharmacometrics Limited by Industry Settings? Session co-organizer, speaker, and moderator. American Conference on Pharmacometrics ACoP15, November 2024.
Pharmacokinetic/Pharmacodynamic Modeling of Monoclonal Antibodies: A Tool for Decision-Making in Drug Development. At PHA6418: Introduction to Model Informed Drug Development Course at University of Florida Center for Pharmacometrics and Systems Pharmacology. Aug 2023, Oct 2024
Clinical Pharmacology (Career Pathways in Industry), with Peter Bonate. Intro to Pharmacy Research 2024, Midwestern University, Chicago College of Pharmacy, Apr 2024
Pharmacokinetic/Pharmacodynamic Modeling of Monoclonal Antibodies: A Tool for Decision-Making in Drug Development. Pharmacokinetics and Pharmacodynamics of Protein Therapeutics. University of Tennessee Health Science Center April 2011-2013, 2015-2019, 2021-2024, 2025
Communication, Negotiation, and Compromise, with Angela James. At Transitioning from Us to Them: A Soft Skills Workshop for Navigating Diverse Teams. American Conference on Pharmacometrics trainee workshop, November 2023
Are you ready for the shark tank?! Trainee Communication challenge, co-organizer and panelist. Lake Nona Leadership Council meeting, University of Florida. March 2023
PMx and QSP: Compare, Contrast, Converge, and Collide– joint presentation with Matthew Riggs. Pharmacometrics and QSP: Convergence, Commonalities, and Continuities” symposium, World Conference on Pharmacometrics (WCoP) April 2022.
Pediatric and Special Population Studies. Clinical Pharmacology in Drug Development Training Course, University of the Pacific. Oct 2021, Oct 2022
Communication and Soft Skills… And Whatever Else You All Want To Talk About!
Indiana University CTSI Disease and Therapeutic Response Modeling and Simulation meeting, Feb 2022
University of Maryland Career Navigation LEAP session, March 2022
Changing How Managers Manage Change Management. At: Integrating Standardization and Innovation In Your Organization: Find A Workflow That Works For You!” American Conference on Pharmacometrics Pre-Conference, ACoP12, Nov 2021
MID3 Roller Coaster Workshop. Facilitator. ASCPT Apr 2021 and Aug 2021
Pharmacometrics: a fitting career for quantitative scientists. University of Augusta Mathematics Department Seminar. Feb 2020
Pharmacometrics: Application of Mathematics, Statistics, and Computer Science (MSCS) to Pharmaceutical Development. Statistics and Data Science Seminar. University of Illinois, Chicago, Sept 2019.
Predicting the Human Pharmacodynamics of Monoclonal Antibodies: Implications for First-in-man Studies.
MID3: Mission Impossible or Model-Informed, Drug Discovery and Development? Point/Counterpoint Discussions on Key Challenges session. ASCPT Annual Meeting, March 2019
Model Less, Communicate More. Primary Limitations To Success
Wrong Models Can Be Dangerous. All Models Are Wrong but Some Are Useful
Visualization Tools for Assessing Reliability of Quantitative Systems Pharmacology Models. Rapid Fire Presentation. AAPS PharmSci 360, Nov 2018
Getting Your Foot on the Rung of the Leadership Ladder. AAPS PharmSci 360, Nov 2018
Resistance is Futile: Changing Minds from “All Models Are Wrong” to “Some Are Useful”. Indiana CTSI Symposium on Disease and Therapeutic Response Modeling and Simulation, Nov 2018
How to train the next generation of Pharmacometricians and Systems Pharmacologists, speaker and panelist. Lake Nona Leadership Council Meeting, March 2018
Pharmacometricians and Statisticians- Can’t We All Just Get Along? “Bridging the Gap between Pharmacometricians and Statisticians” symposium. World Conference on Pharmacometrics (WCoP), Aug 2016
Introduction to M&S and principles of PK/PD modeling.
University of Mississippi, Apr 2016.
Chicago State University AAPS Student Chapter, March 2016.
Role, Accountability, and Skill Sets of Pharmacometricians and Statisticians: Industry Perspective. “Enabling Environments in Which Pharmacometrics and Biostatistics Help Produce Robust Development And Regulatory Strategies” Workshop. American Conference on Pharmacometrics ACoP6 Oct 2015
From Student to Scientist: An Inside Look at Career Opportunities in the Pharma Industry. AAPS Student Event, May 2015
Overview of Pharmacokinetics, Modeling, and simulation and personal career path
“How Not to Get Hired” Panel Discussion: the do’s and don’ts of effective interviewing
Professional Development Session for Students: Effective Communication
AAPS Annual Meeting Oct 2015
American Conference on Pharmacometrics ACoP6 Oct 2015
Principles of Modeling and Simulation. “Five-Part Series on Fundamentals of Clinical Pharmacology for Drug Development”. DIA Webinar, Sept 2014
Introduction to M&S and principles of PK/PD modeling. “PK/PD Principles and Applications”. Applied Pharmaceutical Analysis Short Course, Sept 2014
Leveraging MBDD and business impact in a mid-size company.
At: Is Model-based Drug Development Delivering on its Promise? Assessing the Business Impact. American Conference on Pharmacometrics May 2013
At: Efficiencies of Resource Utilization for MBDD. AAPS Annual Meeting, Nov 2013
Integrating PK and PD Platforms to Remove the ‘Preclinical to Clinical’ Divide and Streamline Drug Development. At: Improved PK/PD Modeling & Analysis to Optimize Translation of Preclinical Data into the Clinic. 5th World PK/PD Summit, March 2013
Modeling and Simulation Support for Design of First-in-Man Studies. At: Minimizing Attrition by Optimizing Integration of Preclinical and Clinical Data”. 3rd Annual World PK/PD Summit: March 2012
Predicting Doses from One Indication to the next for canakinumab, an anti-IL-1beta monoclonal antibody. “Model Based Drug Development: Learning from One Indication to the Next” session. ACCP Annual Meeting, Sept 2011
Quantitative exposure – response evaluations in Preclinical and Early Clinical Development, translational activities and FIH design. “Quantitative Clinical Pharmacology throughout the Discovery and Development Continuum in Inflammation and Immunology” session. ACCP Annual Meeting, Sept 2011
Modeling and Simulation 101. Drug and Biologics Regulatory Training Program at Yale to scientists from the SFDA (Chinese Health Authority). Yale University, New Haven CT. Nov 2010.
Model-based Drug Development: Overview and Current Role in Drug Development. ACCP Annual Meeting. Sept 2010
PK/PD Modeling of Monoclonal Antibodies: A Tool for Decision Making in Drug Development. University of Tennessee, AAPS Visiting Scientist Program, March 2010.
Predicting the Human Pharmacodynamics of Monoclonal Antibodies: Implications for First in Man Studies. ISSX, Oct 2009
Expanding the Xolair dosing table through PKPD modeling. Novartis Respiratory pre-meeting workshop, European Respiratory Society meeting. Sept 2007.
Phase 2a: Proof of Concept. “Satisfying Critical Dose Finding Objectives in Each Stage of the Clinical Process” workshop at the Center for Business Intelligence conference “Dose Finding in Clinical Trials”. Feb 2007
Modeling and Simulation: Learn to Speak the Language. AAPS Annual Meeting, Nov 2006.
A Comparison of Clinical Study Designs using Fixed Dosing (FD) versus Covariate Adjusted Dosing (CAD). At : “Optimizing Dose and Exposure-Response Studies: Reducing Development Time and Expense” Apr 2004.
A Novel Method of Combining Both Continuous and Discrete Categorical Covariates in a Single Joint Function for Generation of Realistic Virtual Patients in a Clinical Trial Simulation. “Population PK/PD on the Cutting Edge” poster- podium session. AAPS Annual Meeting Nov 2002
A Novel Method of Combining Both Continuous and Discrete Categorical Covariates in a Single Joint Function. Center for Drug Development Science Clinical Trial Simulation Workshop. Washington, DC, Aug 2002